Provided by Tiger Trade Technology Pte. Ltd.

Amgen

356.12
+7.692.21%
Volume:234.71K
Turnover:83.26M
Market Cap:191.76B
PE:25.03
High:358.00
Open:350.76
Low:350.76
Close:348.43
52wk High:391.29
52wk Low:261.43
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.40
T/O Rate:0.04%
Dividend:9.66
Dividend Rate:2.71%
EPS(TTM):14.23
EPS(LYR):14.23
ROE:106.10%
ROA:7.93%
PB:22.15
PE(LYR):25.03

Loading ...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galecto (GLTO), Roche Holding AG (OtherRHHVF) and Amgen (AMGN)

TIPRANKS
·
Feb 02

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 02

Assessing Amgen (AMGN) Valuation After Recent Share Price Momentum And Pipeline Expectations

Simply Wall St.
·
Feb 01

Amgen Lawsuit And Eczema Drug Exit Reframe Risk And R&D Priorities

Simply Wall St.
·
Jan 31

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Amgen (AMGN) and Indivior (INDV)

TIPRANKS
·
Jan 31

Amgen to Terminate License, Collaboration Agreement With Kyowa Kirin for Rocatinlimab

MT Newswires Live
·
Jan 30

Amgen, Kyowa Kirin Ending Atopic Dermatitis Drug Collaboration

Dow Jones
·
Jan 30

Amgen Inc -Co and Kyowa Kirin Terminate License and Collaboration Agreement - SEC Filing

THOMSON REUTERS
·
Jan 30

Amgen Inc - Enters Termination Agreement With Kyowa Kirin - SEC Filing

THOMSON REUTERS
·
Jan 30

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Jan 30

Oppenheimer Raises Price Target on Amgen to $400 From $380, Keeps Outperform Rating

MT Newswires Live
·
Jan 29

Amgen price target raised to $400 from $380 at Oppenheimer

TIPRANKS
·
Jan 29

Amgen Inc. to Report Fourth Quarter and Full Year Financial Results

Reuters
·
Jan 29

Pharma Stocks Are Close to 'Breaking Out.' Earnings Could Set Them Free. -- Barrons.com

Dow Jones
·
Jan 29

Amgen Advances Teprotumumab Program With Completed Phase 1 Study in Healthy Chinese Volunteers

TIPRANKS
·
Jan 28

Citi Reaffirms Their Hold Rating on Amgen (AMGN)

TIPRANKS
·
Jan 27

Amgen Is Maintained at Buy by UBS

Dow Jones
·
Jan 27

UBS Adjusts Price Target on Amgen to $390 From $380, Maintains Buy Rating

MT Newswires Live
·
Jan 26

Amgen Inc : UBS Raises Target Price to $390 From $380

THOMSON REUTERS
·
Jan 26

U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies

Reuters
·
Jan 26